Skip to main content
Clinical Trials/NL-OMON23866
NL-OMON23866
Recruiting
Not Applicable

A prospective Study on prevalence and determinants of Ototoxicity dUring treatmeNt of childhooD cancer

Trial Data Center Princes Màxima Center for pediatric oncology0 sites600 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Trial Data Center Princes Màxima Center for pediatric oncology
Enrollment
600
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Trial Data Center Princes Màxima Center for pediatric oncology

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in stratum 1, a subject must meet all of the following criteria:
  • 1\. Diagnosed with a CNS tumor or solid tumor in the Princess Máxima Center and
  • 2\. Planned to receive treatment with cisplatin and/or carboplatin and/ or oxaliplatin and/or CNS\-/ENT irradiation
  • and/or CNS\-/ENT surgery and
  • 3\. Children aged 0 until 19 years at time of diagnosis.
  • 4\. Biobank/ over de drempel PIF, Informed Consent Form (ICF) signed for collection of standard of care data.
  • In order to be eligible to participate in stratum 2, a subject must meet all of the following criteria:
  • 1\. Diagnosed with a CNS tumor or solid tumor in the Princess Máxima Center and
  • 2\. Not planned to receive treatment with cisplatin and/or carboplatin and/or oxaliplatin and/or CNS\-/ENT
  • irradiation and/or CNS\-/ENT surgery and

Exclusion Criteria

  • Critically ill, Intensive Care unit admission because of which audiological evaluation is not possible before
  • start chemotherapy and/or CNS\-/ENTradiotherapy and/or CNS\-/ENT surgery

Outcomes

Primary Outcomes

Not specified

Similar Trials